tradingkey.logo
tradingkey.logo
Buscar

Becton Dickinson and Co

BDX
Añadir a la lista de seguimiento
143.940USD
+3.230+2.30%
Cierre 06/23, 16:00ETCotizaciones retrasadas 15 min
39.66BCap. mercado
36.26P/E TTM

Más Datos de Becton Dickinson and Co Compañía

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Información de Becton Dickinson and Co

Símbolo de cotizaciónBDX
Nombre de la empresaBecton Dickinson and Co
Fecha de salida a bolsaOct 31, 2099
Director ejecutivoPolen (Thomas E)
Número de empleados72000
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 31
DirecciónOne Becton Drive
CiudadFRANKLIN LAKES
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07417-1880
Teléfono12018476800
Sitio Webhttps://www.bd.com/
Símbolo de cotizaciónBDX
Fecha de salida a bolsaOct 31, 2099
Director ejecutivoPolen (Thomas E)

Ejecutivos de Becton Dickinson and Co

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
83.06K
-816.87%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
61.16K
+1.80%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
53.67K
-2.14%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+17.46%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.92K
+0.78%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+22.14%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
10.38K
+10.57%
Mr. Gregory J. Hayes
Mr. Gregory J. Hayes
Independent Director
Independent Director
7.15K
+15.35%
Mr. Vitor Roque
Mr. Vitor Roque
Interim Chief Financial Officer
Interim Chief Financial Officer
7.13K
+24.14%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+28.47%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
83.06K
-816.87%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
61.16K
+1.80%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
53.67K
-2.14%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+17.46%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.92K
+0.78%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+22.14%

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Becton Dickinson and Co?

Los cinco principales accionistas de Becton Dickinson and Co son: Mr. Richard (Rick) Byrd

¿Cuántas instituciones poseen acciones de Becton Dickinson and Co (BDX)?

A fecha de 2026Q1, 2890 instituciones poseen acciones de Becton Dickinson and Co, con un valor de mercado combinado de aproximadamente 241.06M, lo que representa el 87.47% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -46775483.00.

¿Cuál es la mayor fuente de ganancias de Becton Dickinson and Co?

El 2026Q1, el segmento empresarial Medication Delivery Solutions generó la ganancia más alta para Becton Dickinson and Co, ascendiendo a 430.00M y representando el 20.58% de la ganancia total.
KeyAI